APT Therapeutics' Seed VC Round

APT Therapeutics raised a round of funding on June 24, 2002.

APT Therapeutics develops acute-use drugs for controlling clot formation in stroke, pulmonary embolism, myocardial infarction, deep vein thrombosis, and transplantation.…

Articles about APT Therapeutics' Seed VC Round: